About iSpecimen Inc
Ticker
info
ISPC
Trading on
info
NASDAQ
ISIN
info
US45032V1089
Industry
info
Diagnostics & Research
Sector
info
Healthcare
CEO
info
Robert Bradley Lim
Headquarters
info
8 Cabot Road, Woburn, MA, United States, 02420
Employees
info
24
Website
info
https://ispecimen.com
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$6.2M
P/E ratio
info
-
EPS
info
-$8.91
Dividend Yield
info
0.00%
Beta
info
1.77
Forward P/E ratio
info
0
EBIDTA
info
$-10.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$6.2M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1.05
Price to book
info
10.01
Earnings
EPS
info
-$8.91
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-10.7M
Revenues (TTM)
info
$5.9M
Revenues per share (TTM)
info
$3.56
Technicals
Beta
info
1.77
52-week High
info
$4.90
52-week Low
info
$0.55
50-day moving average
info
$1.05
200-day moving average
info
$1.23
Short ratio
info
0.26
Short %
info
1.48%
Management effectiveness
ROE (TTM)
info
-303.74%
ROA (TTM)
info
-76.70%
Profit margin
info
-172.51%
Gross profit margin
info
$1.9M
Operating margin
info
-255.41%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-75.10%
Share stats
Outstanding Shares
info
9.8M
Float
info
5.5M
Insiders %
info
1.22%
Institutions %
info
1.75%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$3.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.19
-$0.28
33.57%
Q2 • 24Beat
-$2.10
-$0.29
-622.55%
Q3 • 24Missed
-$6.28
-$0.31
-1,925.06%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.1M
$-1.7M
-156.82%
Q1 • 25
$0.7M
$-1M
-146.85%
Q2 • 25
-32.56%
-36.85%
-6.36%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$6.8M
$5.2M
75.62%
Q1 • 25
$6M
$5.4M
89.69%
Q2 • 25
-11.82%
4.60%
18.61%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.1M
$0M
$3.8M
$-1.1M
Q1 • 25
$-0.2M
$-0M
$-0M
$-0.2M
Q2 • 25
-82.46%
-∞%
-100.03%
-82.42%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a iSpecimen Inc share?
Collapse

iSpecimen Inc shares are currently traded for undefined per share.

How many shares does iSpecimen Inc have?
Collapse

iSpecimen Inc currently has 9.8M shares.

Does iSpecimen Inc pay dividends?
Collapse

No, iSpecimen Inc doesn't pay dividends.

What is iSpecimen Inc 52 week high?
Collapse

iSpecimen Inc 52 week high is $4.90.

What is iSpecimen Inc 52 week low?
Collapse

iSpecimen Inc 52 week low is $0.55.

What is the 200-day moving average of iSpecimen Inc?
Collapse

iSpecimen Inc 200-day moving average is $1.23.

Who is iSpecimen Inc CEO?
Collapse

The CEO of iSpecimen Inc is Robert Bradley Lim.

How many employees iSpecimen Inc has?
Collapse

iSpecimen Inc has 24 employees.

What is the market cap of iSpecimen Inc?
Collapse

The market cap of iSpecimen Inc is $6.2M.

What is the P/E of iSpecimen Inc?
Collapse

The current P/E of iSpecimen Inc is null.

What is the EPS of iSpecimen Inc?
Collapse

The EPS of iSpecimen Inc is -$8.91.

What is the PEG Ratio of iSpecimen Inc?
Collapse

The PEG Ratio of iSpecimen Inc is null.

What do analysts say about iSpecimen Inc?
Collapse

According to the analysts iSpecimen Inc is considered a buy.